Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 1
1950 1
1961 2
1966 2
1967 2
1969 3
1970 1
1971 1
1973 1
1974 2
1975 4
1976 2
1977 4
1978 5
1979 3
1980 2
1981 1
1982 1
1983 4
1984 4
1985 8
1986 8
1987 7
1988 10
1989 7
1990 14
1991 12
1992 27
1993 35
1994 42
1995 42
1996 33
1997 33
1998 39
1999 35
2000 37
2001 52
2002 43
2003 48
2004 56
2005 59
2006 40
2007 42
2008 50
2009 53
2010 53
2011 42
2012 43
2013 51
2014 45
2015 65
2016 59
2017 67
2018 75
2019 55
2020 69
2021 70
2022 77
2023 57
2024 35

Text availability

Article attribute

Article type

Publication date

Search Results

1,588 results

Results by year

Filters applied: . Clear all
Page 1
Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O, Peter JU. Beth-Tasdogan NH, et al. Among authors: mayer b. Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866376 Free PMC article. Review.
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, Smith SG, Martin N, Mayer B, Yancey SW, Sousa AR, Chan R, Hopkins C; SYNAPSE study investigators. Han JK, et al. Among authors: mayer b. Lancet Respir Med. 2021 Oct;9(10):1141-1153. doi: 10.1016/S2213-2600(21)00097-7. Epub 2021 Apr 16. Lancet Respir Med. 2021. PMID: 33872587
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.
Pavord ID, Chanez P, Criner GJ, Kerstjens HAM, Korn S, Lugogo N, Martinot JB, Sagara H, Albers FC, Bradford ES, Harris SS, Mayer B, Rubin DB, Yancey SW, Sciurba FC. Pavord ID, et al. Among authors: mayer b. N Engl J Med. 2017 Oct 26;377(17):1613-1629. doi: 10.1056/NEJMoa1708208. Epub 2017 Sep 11. N Engl J Med. 2017. PMID: 28893134 Free article. Clinical Trial.
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count.
Bachert C, Sousa AR, Han JK, Schlosser RJ, Sowerby LJ, Hopkins C, Maspero JF, Smith SG, Kante O, Karidi-Andrioti DE, Mayer B, Chan RH, Yancey SW, Chaker AM. Bachert C, et al. Among authors: mayer b. J Allergy Clin Immunol. 2022 May;149(5):1711-1721.e6. doi: 10.1016/j.jaci.2021.10.040. Epub 2022 Jan 7. J Allergy Clin Immunol. 2022. PMID: 35007624 Free article. Clinical Trial.
Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO.
Pavord ID, Chapman KR, Bafadhel M, Sciurba FC, Bradford ES, Schweiker Harris S, Mayer B, Rubin DB, Yancey SW, Paggiaro P. Pavord ID, et al. Among authors: mayer b. Int J Chron Obstruct Pulmon Dis. 2021 Jun 16;16:1755-1770. doi: 10.2147/COPD.S294333. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34163157 Free PMC article.
Editorial.
Mayer BK. Mayer BK. Water Environ Res. 2020 Jun;92(6):794-795. doi: 10.1002/wer.1330. Epub 2020 Apr 15. Water Environ Res. 2020. PMID: 32293772 No abstract available.
1,588 results